Insider Transactions in Q1 2022 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 15
2022
|
Andrea Ellis |
BUY
Open market or private purchase
|
Direct |
12,000
+50.0%
|
$96,000
$8.39 P/Share
|
|
Mar 14
2022
|
Douglas A. Dachille |
BUY
Open market or private purchase
|
Indirect |
10,000
+33.33%
|
$80,000
$8.19 P/Share
|
|
Feb 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,020
-0.33%
|
$8,160
$8.84 P/Share
|
|
Feb 16
2022
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,488
+0.8%
|
-
|
|
Feb 16
2022
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,085
-0.07%
|
$24,680
$8.84 P/Share
|
|
Feb 16
2022
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,524
+0.16%
|
-
|
|
Jan 05
2022
|
Douglas A. Dachille |
BUY
Open market or private purchase
|
Indirect |
5,000
+33.33%
|
$75,000
$15.91 P/Share
|
|
Jan 04
2022
|
Douglas A. Dachille |
BUY
Open market or private purchase
|
Indirect |
5,000
+50.0%
|
$80,000
$16.82 P/Share
|